The Anti-Atherosclerotic Effect of Prosopis Farcta is Associated with the Inhibition of VCAM-1 and ICAM-1

authors:

avatar Gholamreza Bahrami 1 , 2 , avatar Leila Hosseinzadeh 3 , avatar Zahra Azadi 4 , avatar Bahareh Mohammadi 1 , avatar Zahra Mahdiyan 4 , avatar Marziyeh Hajialyani 3 , avatar MohammadHossein Farzaei ORCID 2 , 3 , *

Medical Biology Research Center, Kermanshah, Iran
School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran
Students research committee, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran

how to cite: Bahrami G, Hosseinzadeh L, Azadi Z, Mohammadi B, Mahdiyan Z, et al. The Anti-Atherosclerotic Effect of Prosopis Farcta is Associated with the Inhibition of VCAM-1 and ICAM-1. J Rep Pharm Sci. 2018;7(3):e147504. 

Abstract

This study evaluated the anti-atherosclerosis effect of aqueous extract and polysaccharide-enriched fraction of Prosopis farcta on adhesion and inflammatory cascades in vascular endothelial cells and related molecular mechanisms. Cellular toxicities of LPS, plant extract and polysaccharide-enriched fraction were analyzed in vitro using the MTT method. The ROS accumulation, mRNA expression of ICAM1 and VCAM1, and COX activity were measured in HUVEC cells. These results revealed a new underlying mechanism for anti-atherosclerosis effect of P. farcta and polysaccharide-enriched fraction by attenuating inflammatory cascade mediated by COX expression, modulating expression of cell-adhesion molecules including VCAM-1 and ICAM-1, and diminishing oxidative stress agents.